US Stock MarketDetailed Quotes

LGND Ligand Pharmaceuticals

Watchlist
  • 71.420
  • +1.530+2.19%
Close May 1 16:00 ET
  • 71.560
  • +0.140+0.20%
Post 16:12 ET
1.28BMarket Cap24.29P/E (TTM)

Ligand Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-64.04%49.58M
-84.92%8.07M
-62.68%7.65M
-100.69%-82K
-34.73%33.95M
74.94%137.85M
93.44%53.47M
2.32%20.49M
-41.71%11.88M
383.64%52.01M
Net income from continuing operations
256.33%52.15M
204.02%18.19M
-2,642.82%-10.27M
355.87%2.29M
372.66%41.95M
-158.39%-33.36M
-222.84%-17.49M
-97.06%404K
-102.91%-895K
-184.97%-15.39M
Operating gains losses
-43.31%-46.91M
67.35%-14.45M
19,308.77%11.06M
-3,570.43%-3.99M
-448.46%-39.53M
-389.66%-32.73M
-464.73%-44.25M
103.15%57K
-98.75%115K
237.52%11.35M
Depreciation and amortization
-30.62%35.64M
-19.88%8.92M
-36.75%8.54M
-30.77%9.06M
-33.16%9.12M
0.83%51.37M
-14.01%11.13M
7.07%13.51M
6.47%13.09M
4.21%13.64M
Deferred tax
-43.56%11.7M
-89.34%4.94M
163.32%8.01M
-407.22%-10M
154.10%8.75M
340.46%20.72M
12,000.51%46.29M
-922.71%-12.65M
23.20%3.26M
-30.40%-16.18M
Other non cash items
-58.29%2.45M
-66.43%712K
-72.53%420K
-20.78%1.21M
-84.02%112K
142.37%5.87M
-75.48%2.12M
294.53%1.53M
105.33%1.52M
-89.75%701K
Change In working capital
-152.38%-34.4M
-160.18%-15.99M
-515.73%-20.83M
62.74%-5.48M
-83.81%7.9M
215.21%65.68M
349.36%26.57M
133.31%5.01M
8.86%-14.7M
421.42%48.79M
-Change in receivables
-104.70%-2.6M
-91.85%2.84M
-197.67%-7.91M
106.74%1.38M
-97.48%1.1M
293.31%55.32M
275.80%34.77M
56.98%-2.66M
-302.96%-20.43M
1,709.95%43.64M
-Change in inventory
-190.15%-10.87M
-47.86%707K
-163.51%-611K
-234.09%-13M
4,525.00%2.04M
2,923.89%12.06M
-49.33%1.36M
223.81%962K
32.03%9.7M
100.46%44K
-Change in payables and accrued expense
-40.84%-4.7M
193.94%2.76M
-163.28%-2.5M
-174.41%-4.53M
83.94%-435K
-218.86%-3.34M
-145.54%-2.94M
460.57%3.95M
65.72%-1.65M
-676.17%-2.71M
-Change in other working capital
-1,089.45%-16.23M
-222.11%-21.37M
-486.94%-10.73M
561.24%10.67M
-33.50%5.2M
105.33%1.64M
-663,600.00%-6.64M
131.53%2.77M
82.97%-2.31M
193.16%7.82M
Cash from discontinued investing activities
Operating cash flow
-64.04%49.58M
-84.92%8.07M
-62.68%7.65M
-100.69%-82K
-34.73%33.95M
74.94%137.85M
93.44%53.47M
2.32%20.49M
-41.71%11.88M
383.64%52.01M
Investing cash flow
Cash flow from continuing investing activities
-107.14%-11.68M
-41.19%-10.28M
-201.71%-19.5M
-80.04%7.56M
-90.74%10.55M
436.07%163.62M
79.60%-7.28M
205.26%19.18M
95.73%37.85M
74.89%113.88M
Net PPE purchase and sale
80.35%-3.52M
80.43%-417K
88.75%-487K
96.92%-203K
50.48%-2.41M
-104.58%-17.92M
2.92%-2.13M
-144.30%-4.33M
-373.96%-6.59M
-43.21%-4.88M
Net intangibles purchase and sale
-54,350.00%-49.91M
-4,877.47%-50.26M
114.17%136K
--83K
--130K
-81.38%92K
112.96%1.05M
---960K
--0
--0
Net business purchase and sale
-3,320.53%-25.65M
---14K
---25.64M
--0
--0
---750K
--0
--0
--0
---750K
Net investment purchase and sale
-63.20%67.4M
882.30%40.41M
-73.43%6.49M
-82.71%7.68M
-89.26%12.83M
357.80%183.17M
84.18%-5.17M
248.48%24.42M
118.18%44.41M
73.80%119.51M
Net other investing changes
----
----
----
----
----
21.31%-960K
23.25%-1.04M
--47K
----
----
Cash from discontinued investing activities
Investing cash flow
-107.14%-11.68M
-41.19%-10.28M
-201.71%-19.5M
-80.04%7.56M
-90.74%10.55M
436.07%163.62M
79.60%-7.28M
205.26%19.18M
95.73%37.85M
74.89%113.88M
Financing cash flow
Cash flow from continuing financing activities
78.28%-59.95M
200.32%5.32M
108.01%3.27M
-13.99%-67.76M
99.55%-775K
-100.34%-275.99M
-227.23%-5.3M
-10,504.94%-40.83M
-19.11%-59.44M
-85.98%-170.42M
Net issuance payments of debt
70.54%-76.9M
16.67%-45K
--0
-28.21%-76.84M
99.99%-13K
-58.23%-261M
---54K
-1,482.43%-37.65M
-20.00%-59.93M
-45.06%-163.37M
Proceeds from stock option exercised by employees
594.55%22.45M
365.81%6.53M
313.05%3.39M
1,276.81%9.14M
877.81%3.39M
-90.43%3.23M
-67.26%1.4M
-56.84%820K
-39.14%664K
-98.69%347K
Net other financing activities
69.83%-5.5M
82.45%-1.17M
97.08%-117K
66.28%-58K
43.84%-4.16M
-177.05%-18.22M
-5,678.26%-6.65M
-4,358.51%-4M
83.62%-172K
-34.41%-7.4M
Cash from discontinued financing activities
Financing cash flow
78.28%-59.95M
200.32%5.32M
108.01%3.27M
-13.99%-67.76M
99.55%-775K
-100.34%-275.99M
-227.23%-5.3M
-10,504.94%-40.83M
-19.11%-59.44M
-85.98%-170.42M
Net cash flow
Beginning cash position
130.54%45.01M
382.46%19.86M
438.73%28.45M
491.80%88.73M
130.54%45.01M
-59.30%19.52M
-82.43%4.12M
-76.01%5.28M
-53.43%14.99M
-59.30%19.52M
Current changes in cash
-186.53%-22.05M
-92.43%3.1M
-637.71%-8.59M
-520.64%-60.28M
1,065.38%43.72M
189.61%25.48M
1,146.58%40.89M
-181.80%-1.16M
4.68%-9.71M
71.27%-4.53M
End cash Position
-49.00%22.95M
-49.00%22.95M
382.46%19.86M
438.73%28.45M
491.80%88.73M
130.54%45.01M
130.54%45.01M
-82.43%4.12M
-76.01%5.28M
-53.43%14.99M
Free cash flow
-103.56%-4.27M
-181.60%-42.68M
-52.90%7.16M
-105.39%-285K
-33.10%31.53M
71.23%119.93M
105.53%52.3M
-16.73%15.2M
-72.14%5.29M
541.31%47.14M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -64.04%49.58M-84.92%8.07M-62.68%7.65M-100.69%-82K-34.73%33.95M74.94%137.85M93.44%53.47M2.32%20.49M-41.71%11.88M383.64%52.01M
Net income from continuing operations 256.33%52.15M204.02%18.19M-2,642.82%-10.27M355.87%2.29M372.66%41.95M-158.39%-33.36M-222.84%-17.49M-97.06%404K-102.91%-895K-184.97%-15.39M
Operating gains losses -43.31%-46.91M67.35%-14.45M19,308.77%11.06M-3,570.43%-3.99M-448.46%-39.53M-389.66%-32.73M-464.73%-44.25M103.15%57K-98.75%115K237.52%11.35M
Depreciation and amortization -30.62%35.64M-19.88%8.92M-36.75%8.54M-30.77%9.06M-33.16%9.12M0.83%51.37M-14.01%11.13M7.07%13.51M6.47%13.09M4.21%13.64M
Deferred tax -43.56%11.7M-89.34%4.94M163.32%8.01M-407.22%-10M154.10%8.75M340.46%20.72M12,000.51%46.29M-922.71%-12.65M23.20%3.26M-30.40%-16.18M
Other non cash items -58.29%2.45M-66.43%712K-72.53%420K-20.78%1.21M-84.02%112K142.37%5.87M-75.48%2.12M294.53%1.53M105.33%1.52M-89.75%701K
Change In working capital -152.38%-34.4M-160.18%-15.99M-515.73%-20.83M62.74%-5.48M-83.81%7.9M215.21%65.68M349.36%26.57M133.31%5.01M8.86%-14.7M421.42%48.79M
-Change in receivables -104.70%-2.6M-91.85%2.84M-197.67%-7.91M106.74%1.38M-97.48%1.1M293.31%55.32M275.80%34.77M56.98%-2.66M-302.96%-20.43M1,709.95%43.64M
-Change in inventory -190.15%-10.87M-47.86%707K-163.51%-611K-234.09%-13M4,525.00%2.04M2,923.89%12.06M-49.33%1.36M223.81%962K32.03%9.7M100.46%44K
-Change in payables and accrued expense -40.84%-4.7M193.94%2.76M-163.28%-2.5M-174.41%-4.53M83.94%-435K-218.86%-3.34M-145.54%-2.94M460.57%3.95M65.72%-1.65M-676.17%-2.71M
-Change in other working capital -1,089.45%-16.23M-222.11%-21.37M-486.94%-10.73M561.24%10.67M-33.50%5.2M105.33%1.64M-663,600.00%-6.64M131.53%2.77M82.97%-2.31M193.16%7.82M
Cash from discontinued investing activities
Operating cash flow -64.04%49.58M-84.92%8.07M-62.68%7.65M-100.69%-82K-34.73%33.95M74.94%137.85M93.44%53.47M2.32%20.49M-41.71%11.88M383.64%52.01M
Investing cash flow
Cash flow from continuing investing activities -107.14%-11.68M-41.19%-10.28M-201.71%-19.5M-80.04%7.56M-90.74%10.55M436.07%163.62M79.60%-7.28M205.26%19.18M95.73%37.85M74.89%113.88M
Net PPE purchase and sale 80.35%-3.52M80.43%-417K88.75%-487K96.92%-203K50.48%-2.41M-104.58%-17.92M2.92%-2.13M-144.30%-4.33M-373.96%-6.59M-43.21%-4.88M
Net intangibles purchase and sale -54,350.00%-49.91M-4,877.47%-50.26M114.17%136K--83K--130K-81.38%92K112.96%1.05M---960K--0--0
Net business purchase and sale -3,320.53%-25.65M---14K---25.64M--0--0---750K--0--0--0---750K
Net investment purchase and sale -63.20%67.4M882.30%40.41M-73.43%6.49M-82.71%7.68M-89.26%12.83M357.80%183.17M84.18%-5.17M248.48%24.42M118.18%44.41M73.80%119.51M
Net other investing changes --------------------21.31%-960K23.25%-1.04M--47K--------
Cash from discontinued investing activities
Investing cash flow -107.14%-11.68M-41.19%-10.28M-201.71%-19.5M-80.04%7.56M-90.74%10.55M436.07%163.62M79.60%-7.28M205.26%19.18M95.73%37.85M74.89%113.88M
Financing cash flow
Cash flow from continuing financing activities 78.28%-59.95M200.32%5.32M108.01%3.27M-13.99%-67.76M99.55%-775K-100.34%-275.99M-227.23%-5.3M-10,504.94%-40.83M-19.11%-59.44M-85.98%-170.42M
Net issuance payments of debt 70.54%-76.9M16.67%-45K--0-28.21%-76.84M99.99%-13K-58.23%-261M---54K-1,482.43%-37.65M-20.00%-59.93M-45.06%-163.37M
Proceeds from stock option exercised by employees 594.55%22.45M365.81%6.53M313.05%3.39M1,276.81%9.14M877.81%3.39M-90.43%3.23M-67.26%1.4M-56.84%820K-39.14%664K-98.69%347K
Net other financing activities 69.83%-5.5M82.45%-1.17M97.08%-117K66.28%-58K43.84%-4.16M-177.05%-18.22M-5,678.26%-6.65M-4,358.51%-4M83.62%-172K-34.41%-7.4M
Cash from discontinued financing activities
Financing cash flow 78.28%-59.95M200.32%5.32M108.01%3.27M-13.99%-67.76M99.55%-775K-100.34%-275.99M-227.23%-5.3M-10,504.94%-40.83M-19.11%-59.44M-85.98%-170.42M
Net cash flow
Beginning cash position 130.54%45.01M382.46%19.86M438.73%28.45M491.80%88.73M130.54%45.01M-59.30%19.52M-82.43%4.12M-76.01%5.28M-53.43%14.99M-59.30%19.52M
Current changes in cash -186.53%-22.05M-92.43%3.1M-637.71%-8.59M-520.64%-60.28M1,065.38%43.72M189.61%25.48M1,146.58%40.89M-181.80%-1.16M4.68%-9.71M71.27%-4.53M
End cash Position -49.00%22.95M-49.00%22.95M382.46%19.86M438.73%28.45M491.80%88.73M130.54%45.01M130.54%45.01M-82.43%4.12M-76.01%5.28M-53.43%14.99M
Free cash flow -103.56%-4.27M-181.60%-42.68M-52.90%7.16M-105.39%-285K-33.10%31.53M71.23%119.93M105.53%52.3M-16.73%15.2M-72.14%5.29M541.31%47.14M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg